“…GnRH, which acts on the pituitary via direct innervation, stimulates the secretion of gonadotropins (GtH) that act on the gonad resulting in the production of steroids and prostaglandins (Rottmann et al, ). Since the discovery of the GnRH decapeptide and its associated role in the HPG axis, a large body of research has focused on optimization of dose, identification of active variants and development of potent analogues (Alok, Talwar, & Garg, ; Bosma, Rebers, Dijk, Willems, & Goos, ; DiMaggio et al, ; DiMaggio, Broach, & Ohs, ; Forniés et al, ; Lovejoy et al, ; Mikolajczyk et al, ; Mylonas, Hinshaw, & Sullivan, ; Ngamvongchon, Rivier, & Sherwood, ; Podhorec & Kouril, ; Prayogo, Wijayanti, Sulistyo, & Sukardi, ; Quiniou, Bosworth, Chatakondi, & Oberle, ; Sahoo, Giri, & Sahu, ; Szabó, Radics, Barth, & Horváth, ; Taufek, Harmin, & Christianus, ; Zohar et al, ). One advantage of using GnRH is that it occurs earlier in the hormonal cascade stimulating the release of endogenous stores of GtH and facilitating the contribution of supplementary endocrine factors such as prolactin, thyroid hormones, insulin like growth factors and growth hormone (Podhorec & Kouril, ).…”